NP2

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Legal Domicile

Principal Officer

Khalid Shah

Phone

4156024281

Tax Period

2025-10-01 to 2025-12-31

NP2, founded in 2019, is a micro nonprofit in the Medical Research sector that reported $59K in total revenue in fiscal year 2025. Revenue fell 39% from the prior year — a significant decline worth monitoring. Expenses of $65K exceeded revenue, resulting in a 10% operating deficit.

Mission

NP2 promotes public health by developing, manufacturing, and distributing affordable medicines targeted at prevention and treatment of diseases in underserved or distressed populations.

Program Service Accomplishments

Program 1

Expenses: $40,048

NP2 develops, manufactures, and distributes medications for the use in the treatment of infectious diseases and cancer.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $56,150

Program Service Revenue $0

Investment Income $2,582

Other Revenue $0

TOTAL REVENUE $58,732

Expense Breakdown

Grants Paid $0

Salaries & Benefits $40,950

Fundraising Expenses $0

Program Expenses $40,048

Other Expenses $23,682

TOTAL EXPENSES $64,632

Year-over-Year Comparison

	2025	2024	Change
Revenue	$58,732	$96,607	-0.4%
Expenses	$64,632	$290,774	-0.8%
Net Income	$-5,900	$-194,167	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$162,500

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Terri Miller	Exec Director	20.00	Officer	$162,500	$0	$162,500
Khalid Shah	President	20.00	Officer Director	$0	$0	$0
Jacob P Lalezari	Vice President	2.00	Officer Director	$0	$0	$0
David Figg	Treasurer	1.00	Officer Director	$0	$0	$0
Donna Kato	Secretary	1.00	Officer Director	$0	$0	$0
Jodi Andrews	Director	1.00	Director	$0	$0	$0
Joseph Jacobson	Director	1.00	Director	$0	$0	$0
Jon Nygaard	Director	1.00	Director	$0	$0	$0
William Buhles	Dir Emeritus	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$58,732	$64,632	$658,182	$-5,900
2024	$570,351	$282,025	$858,249	$288,326
2023	$572,902	$106,933	$506,971	$465,969
2021	No data	$150,141	$116,104	No data
2020	$340,500	$122,705	$266,245	$217,795